Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
October 17, 2016 – The FDA announced the discontinuation of Endo’s Sumavel DosePro (sumatriptan) 4 mg/0.5 mL injection.
Download PDF
Return to publications
